EZH2 and Miyoshi myopathy: Thereafter, we used Western blot to verify that the EZH2 inhibitor GSK503 inhibited the downstream functional protein H3K27me3 of EZH2 in MM cell lines OPM-2 and RPMI-8226 in 10 μM (Figure 1C).